In Focus: Compliance and Start-ups

Posted 01 May 2010 | By

Start-up companies and others in the early phases of drug, biologic and device development face a variety of issues and pitfalls. In addition to obtaining financing, these firms need an effective strategy and tactics to get from one milestone to the next. During this process, the company must, of course, follow the rules and regulations associated with bringing the product to market.

Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe